on 29 Sep 2020
Last Applicant/ Owned by
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
Serial Number
88377499 filed on 09th Apr 2019
Registration Number
6161315 registered on 29th Sep 2020
Correspondent Address
Frances M. Jagla
Filing Basis
1. intent to use
Disclaimer
NO DATA
research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; Read More
research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
N/A
N/A
pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
N/A
N/A
No 88377499
No Service Mark
No 2854-T404US
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
17th Jun 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
17th Jun 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
17th Jun 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
17th Jun 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
17th Jun 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
01st May 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
24th Apr 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
29th Sep 2020 | REGISTERED-PRINCIPAL REGISTER |
14th Jul 2020 | PUBLISHED FOR OPPOSITION |
14th Jul 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |